Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
14/10/2026 07:03
BRIEF-Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations Oct 14 (Reuters) - Evotec SE EVTG.DE :
SAID ON TUESDAY PRELIMINARY 9M 2026 RESULTS ABOVE MARKET EXPECTATIONS
EXPECTS 9M 2026 GROUP REVENUES OF €465 MLN
EXPECTS 9M 2026 ADJ GROUP EBITDA OF -€42.80 MLN
REAFFIRMS FY2026 GUIDANCE
Source text: nEQ2zrGx1a
Further company coverage: EVTG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases